Recent Updates
Recently added Catalysts
STXS Positive Sentiment

Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023

Key Takeaway: Stereotaxis, a leader in surgical robotics for minimally invasive procedures, will announce its third quarter 2023 financial results on November 9, 2023. A conference call will be held at 10 a.m. EST to discuss these results and related corporate developments. The company aims to improve patient care with their innovative robotics technology, having treated over 100,000 patients globally.
Price reaction · baseline $1.55 (2023-10-16 close) · hit after-hours · clean, no other STXS news in the window
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Stereotaxis will report third quarter financial results soon.
  • The company has a strong position in surgical robotics.
  • Innovations from Stereotaxis aim to enhance patient care.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~8 mo
Medium dilution risk
Lead asset
Vdrive Lasso navigation, Manual Lasso navigation
Phase 3 · Atrial Fibrillation

Full Press Release Details

ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 third quarter on Thursday, November 9, 2023 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.
What: Stereotaxis third quarter 2023 financial results conference call
When: Thursday, November 9, 2023, at 10:00 a.m. EST (7:00 a.m. PST)
Dial In Number: To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 3519052.
Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/ .
Call Replay: A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here .
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Frequently Asked Questions

When will Stereotaxis report its Q3 2023 financial results?

Stereotaxis will release its Q3 2023 financial results on November 9, 2023.

What time is the Stereotaxis conference call?

The conference call will be held at 10 a.m. EST on November 9, 2023.

How can I access the Stereotaxis conference call?

Dial 800-715-9871 for US calls or 1-646-307-1963 internationally.

Where can I find the Stereotaxis call replay?

The call replay will be available through the investor relations section on their website.

What is Stereotaxis known for?

Stereotaxis specializes in surgical robotics for minimally invasive endovascular interventions.

Last updated: Oct 17, 2023